Retractable Technologies, Inc. filings document the regulatory record for a Texas medical device manufacturer whose common stock trades on NYSE American under RVP. Recent Form 8-K reports cover material events such as operating-results releases, workforce reductions, product designation announcements, and dividends on Series II and Series III Class B Convertible Preferred Stock.
The company’s proxy materials disclose annual meeting matters, director elections, board structure, shareholder voting procedures, and executive-governance information. Together, the filings describe Retractable’s public-company capital structure, recurring event disclosures, governance processes, and formal exhibits tied to its safety medical products business.
Retractable Technologies (RVP) filed a Form 4 showing that President, CEO, Director and 10% owner Thomas J. Shaw bought 1,575 common shares on 08/01/2025 at a weighted-average price of $0.703. The transaction was coded “P” (open-market purchase) and executed under a Rule 10b5-1 plan adopted 08/22/2024.
Following the purchase, Shaw directly owns 15,498,332 shares and holds indirect control over an additional 831,600 shares—bringing his total beneficial interest to roughly 16.3 million shares. The incremental buy represents less than 0.01% of his existing stake, so economic impact is minimal, yet the action reiterates insider alignment at a depressed price level. No derivative security activity was reported.
Retractable Technologies, Inc. (RVP) – Form 4 insider transaction
President, CEO, Director and 10% owner Thomas J. Shaw reported an open-market purchase (transaction code P) of company common stock on 30 June 2025. Shaw acquired 1,347 shares at a weighted-average price of $0.6221 per share pursuant to a Rule 10b5-1 trading plan adopted on 22 Aug 2024.
- Direct ownership after the trade: 15,442,020 shares
- Indirect ownership (trust & voting agreement): 831,600 shares
- Total reported beneficial ownership (direct + indirect): 16,273,620 shares
No derivative securities were reported in Table II. The filing indicates Shaw remains a key insider (Director, CEO, 10% holder) and the form was signed on 1 July 2025.